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Summary. The tyrosine kinase receptor c-kit and its 
ligand [kit ligand (KL) or stem cell factor (SCF)] exert a 
broad range of biological activities during organogenesis 
and normal cell development. Recent studies have 
revealed that altered c-kit levels occur in a variety of 
malignancies and cancer cell lines. KL has also been 
shown to stimulate the growth of malignant cells, as well 
as to promote chemotaxis. We had previously reported 
expression of KL in stroma cells of normal human 
prostate. 
The present study was undertaken in order to 
analyze the patterns of expression of c-kit and KL in a 
well characterized set of prostatic tissues, including 
normal prostate (n=4), benign prostatic hyperplasia 
(BPH) (n=53) and adenocarcinoma (n=46) samples. The 
distribution of c-kit and KL proteins was studied by 
immunohistochemical analyses, while transcript levels 
were determined by in situ hybridization with specific 
RNA probes on a subset of the benign and malignant 
tissues referred above. In addition, reverse-transcriptase 
polymerase chain reaction (RT-PCR) was performed to 
determine levels of c-kit and KL expression in cultures 
of epithelial and stroma cells, as well as in the prostate 
cancer cell lines LNCaP, DUI45 and PC3. 
c-kit protein in normal prostate was exclusively 
detected in mast cells by immunohistochemistry and in 
situ hybridization. However, c-kit transcripts, but not c- 
kit protein, were detected in low levels and with an 
heterogeneous pattern in basal epithelial cells of ducts 
and acini. c-kit in BPH was detected in epithelial cells in 
9 of 53 (17%) specimens. c-kit protein expression in 
malignant epithelial cells was identified in 1 of 46 (2%) 
tumors. However, c-kit transcripts were detected in low 
levels by in situ hybridization in most of the tumors 
analyzed. 
KL protein and transcripts in normal prostate were 
detected in high levels in stroma cells.  However, 
epithelial cells were unreactive for anti-KL antibody, but 
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showed low levels of KL transcripts mainly in cells of 
the basal layer. Basal epithelial cells in hyperplastic 
glands showed K L  expression in 1 3  of 5 3  (24%) 
specimens. KL protein in tumor cells was noted in 18 of 
46 (39%) cases. 
c-kit transcripts were not found in normal prostate 
and in the 3 cancer cell lines analyzed by RT-PCR, 
however, it was present in cultured epithelial cells of 
BPH, and in cultures of stroma cells from both normal 
and BPH. The majority of cultured cell lines of epithelial 
and stromal origin displayed considerable levels of KL. 
In addition all prostate cell lines studied showed 
significant levels of KL transcripts. 
In summary, CO-expression of c-kit and KL in a 
subset of BPH cases may suggest an autocrine mode of 
signaling. Data from this study reveals that altered 
patterns of c-kit and KL expression are associated with 
BPH and adenocarcinoma of prostate. It appears that KL 
induces mast cells proliferation and maturation and 
enhances their release of protease. This could explain the 
accumulation of mast cells at tumor sites. a phenomenon 
that was not observed in normal prostate or BPH 
samples. 
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Introduction 
c-kit is a 145-160 kD transmembrane glycoprotein 
receptor of the tyrosine kinase family, which shares 
structural similarities with the receptors for the 
macrophage growth factor and for the platelet derived 
growth factor (Yarden et al., 1987). Mutations at the 
murine 'W' (white spotting) locus, homologous to the 
human c-kit, affect the development of hematopoietic 
stem cells, melanoblasts and primordial germ cells 
(Nocka et al., 1989), resulting in anemia, mast cell 
deficiency, depigmentation and sterility. A peptide 
growth factor has been identified as the ligand of c-kit, 
and alternately termed kit-ligand (KL), stem cell factor 
(SCF) or mast cell growth factor (MGF) (Huang et al., 









